First Berlin keeps MaaT Pharma rating, price target under review
Bitget2026/10/07 12:10First Berlin Equity Research kept its rating on MaaT Pharma at Under Review, with the price target also Under Review. The update followed a CHMP negative opinion on MaaT013’s conditional European filing, citing limits of the single-arm ARES Phase 3 dataset. Strategy now centers on PHOENIX, a global randomized Phase 3 trial versus best available therapy in about 138 patients. FDA Type C feedback supports PHOENIX as a registrational trial, with first patient enrollment possible in H1 2027. Cash totaled EUR 17.1 million at end-June; runway now seen through December 2026, leaving a major funding gap for PHOENIX. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maat Pharma SA published the original content used to generate this news brief via EQS News (Ref. ID: rc_27032) on October 07, 2026, and is solely responsible for the information contained therein.
- First Berlin Equity Research kept its rating on MaaT Pharma at Under Review, with the price target also Under Review.
- The update followed a CHMP negative opinion on MaaT013’s conditional European filing, citing limits of the single-arm ARES Phase 3 dataset.
- Strategy now centers on PHOENIX, a global randomized Phase 3 trial versus best available therapy in about 138 patients.
- FDA Type C feedback supports PHOENIX as a registrational trial, with first patient enrollment possible in H1 2027.
- Cash totaled EUR 17.1 million at end-June; runway now seen through December 2026, leaving a major funding gap for PHOENIX.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SNT Holdings, Related Party Raise Combined Stake in SNTEnergy to 55.75% From 52.75%
Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high
Japan's spot electricity prices surged to multi-year highs over the weekend.
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail
Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.
Canaccord Genuity: Lowers Oklo's target price to $66
Crypto prices
More
